What is the global market size of the Orthobiologics Market?

Global Global Orthobiologics Market size was valued at USD 7.63 billion in 2021 and is poised to grow from USD 8.56 billion in 2022 to USD 12.33 billion by 2030, growing at a CAGR of 5.4% in the forecast period (2023-2030).

Orthobiologics Market Size, Share, Growth Analysis, By Product (Viscosupplementation Products, Demineralized Bone Matrices), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion), By End User (Hospitals, Orthopedic Clinics, & Ambulatory Care Centers), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2070 | Region: Global | Published Date: September, 2024
Pages: 157 | Tables: 92 | Figures: 76

Orthobiologics Market Insights

Global Orthobiologics Market size was valued at USD 6.1 billion in 2022 and is poised to grow from USD 6.43 billion in 2023 to USD 9.87 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2024-2031).

The rise in the frequency of sports injuries and traffic accidents are two important factors anticipated to propel the growth of the orthobiologics market during the forecast period. It is projected that the market for orthobiologics would grow as a result of the rise in spinal diseases and disorders. It is also predicted that the growing patient desire for minimally invasive procedures will restrain the expansion of the orthobiologics market. However, the rise in the price of orthobiologics-based treatments may restrain the market's expansion throughout the forecast period. The market for orthobiologics is expanding at an accelerated rate due to the rise in the elderly and obese population.

Regenerative cellular therapies are another name for orthobiologics. Orthobiologic products contain growth factors that improve and stimulate discomfort, promote tissue healing, and aid in restoring normal function.

US Orthobiologics Market is poised to grow at a sustainable CAGR for the next forecast year.

Orthobiologics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Medtronic has become the market leader because of the excellent introduction and quick uptake of infuse bone morphogenetic protein. Medtronic is anticipated to hold the largest share during the forecast period due to infuse's higher price, strong sales team, and April 2018 FDA clearance for use in a new indication for spine surgery. Musculoskeletal Transplant Foundation, Zimmer Biomet, Wright Medical Group N.V., DePuy Synthes (Johnson & Johnson Services, Inc.), Stryker, Sea Spine, Bioventus, RTI Surgical Holdings, Inc. and Anika Therapeutics, Inc. are additional companies that compete on the international market. 'Medtronic plc', 'Stryker Corporation ', 'Globus Medical, Inc. ', 'Orthofix International N.V. ', 'RTI Surgical, Inc. ', 'Kuros Biosciences Ltd. ', 'Bioventus LLC ', 'Nuvasive, Inc. ', 'Seaspine Holdings Corporation ', 'Arthrex, Inc. ', 'Xtant Medical Holdings, Inc. ', 'Sanofi S.A. ', 'Smith & Nephew plc ', 'Integra LifeSciences Holdings Corporation ', 'Anika Therapeutics, Inc. ', 'Alphatec Spine, Inc. ', 'Orthocell Ltd. ', 'MiMedx Group, Inc. ', 'Orthofix Medical Inc. ', 'Bone Therapeutics SA'

One of the main issues affecting the elderly population is knee osteoarthritis, which is extensively treated with viscosupplements. Hyaluronic acid injections known as viscosupplements are given right into the joints. High product costs, new manufacturer entrants, and recent marketing approvals are the major variables linked to the expansion of viscosupplements segments. Additionally, the viscosupplements segments are benefiting from better reimbursement policies. Given the aforementioned aspects, it is projected that the increased demand for viscosupplements will propel the growth of the worldwide orthobiologics market during the forecast period.

The global orthobiologics market is anticipated to develop due to the high prevalence of sports-related injuries. For instance, according to a study published in November 2018 titled "Results on sports-related injuries in children from NHS emergency care dataset Oxfordshire pilot: an ecological study," 47.4 percent of emergency department visits related to sports injuries were for children between the ages of 0 and 19 and roughly 23.5 percent of admissions related to sports injuries for all ages.

Orthopedic Surgery in outpatient settings is increasing, favoring the North American Market. North America's market is estimated to rule the industry for the entire forecast year. The market in North America may see growth between 2019 and 2026 as a result of the business strategies of top American manufacturers, benevolent reimbursement policies, rising prevalence of degenerative bone diseases, and rising trend of orthopaedic procedures in outpatient settings. Due to the recent marketing approval for Cingal, a viscosupplement, in Europe, Europe is anticipated to be the second most lucrative region with a sizable market share..

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Orthobiologics Market Insights

Orthobiologics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Orthobiologics Market?

Who are the key vendors in the Orthobiologics Market?

What is the key driver of Orthobiologics Market?

What is the key market trend for Orthobiologics Market?

Which region accounted for the largest share in Orthobiologics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300